Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1977 Nov;60(5):999–1007. doi: 10.1172/JCI108880

Release of platelet constituents by monosodium urate crystals.

M H Ginsberg, F Kozin, M O'Malley, D J McCarty
PMCID: PMC372451  PMID: 908764

Abstract

The release of human platelet constituents by the etiologic agent of gout, the monosodium urate crystal, is described here. In suspensions of washed platelets, response to urate crystals proceeded in two phases: A secretory phase involved the rapid active release of serotonin, ATP, and ADP with little loss of lactic dehydrogenase or beta-glucuronidase. A lytic phase involved the slower loss of all platelet constituents. Both phases were inhibited by iodoacetate plus dinitrophenol, suggesting an energy requirement. In ultrastructural studies, lysis of washed platelets which appeared to contain crystals was seen. Urate crystals were also shown to induce serotonin release and platelet lysis in citrated platelet-rich plasma. Since urate crystals are deposited at a variety of sites, urate crystal-platelet interaction in vivo is a possibility. Such interactions, leading to release of platelet constituents, might contribute to gouty inflammation or to enhanced atherogenesis.

Full text

PDF
999

Images in this article

1002Image
on p.1002
1003Image
on p.1003
1004Image
on p.1004

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTER R. H., JANDL J. H. PLATELET SEQUESTRATION IN MAN. I. METHODS. J Clin Invest. 1964 May;43:843–855. doi: 10.1172/JCI104970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Colman R. W. Formation of human plasma kinin. N Engl J Med. 1974 Sep 5;291(10):509–515. doi: 10.1056/NEJM197409052911008. [DOI] [PubMed] [Google Scholar]
  3. GLYNN M. F., MOVAT H. Z., MURPHY E. A., MUSTARD J. F. STUDY OF PLATELET ADHESIVENESS AND AGGREGATION, WITH LATEX PARTICLES. J Lab Clin Med. 1965 Feb;65:179–201. [PubMed] [Google Scholar]
  4. HARDISTY R. M., HUTTON R. A. THE KAOLIN CLOTTING TIME OF PLATELET-RICH PLASMA: A TEST OF PLATELET FACTOR-3 AVAILABILITY. Br J Haematol. 1965 May;11:258–268. doi: 10.1111/j.1365-2141.1965.tb06586.x. [DOI] [PubMed] [Google Scholar]
  5. HUMPHREY J. H., JAQUES R. The release of histamine and 5-hydroxytryptamine (serotonin) from platelets by antigen-antibody reactions (in vitro). J Physiol. 1955 Apr 28;128(1):9–27. doi: 10.1113/jphysiol.1955.sp005289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hall A. P. Correlations among hyperuricemia, hypercholesterolemia, coronary disease and hypertension. Arthritis Rheum. 1965 Oct;8(5):846–852. doi: 10.1002/art.1780080449. [DOI] [PubMed] [Google Scholar]
  7. Henson P. M. Mechanisms of release of constituents from rabbit platelets by antigen-antibody complexes and complement. II. Interaction of platelets with neutrophils. J Immunol. 1970 Aug;105(2):490–501. [PubMed] [Google Scholar]
  8. Henson P. M., Spiegelberg H. L. Release of serotonin from human platelets induced by aggregated immunoglobulins of different classes and subclasses. J Clin Invest. 1973 May;52(5):1282–1288. doi: 10.1172/JCI107296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Holmsen H., Day H. J. The selectivity of the thrombin-induced platelet release reaction: subcellular localization of released and retained constituents. J Lab Clin Med. 1970 May;75(5):840–855. [PubMed] [Google Scholar]
  10. Holmsen H., Storm E., Day H. J. Determination of ATP and ADP in blood platelets: a modification of the firefly luciferase assay for plasma. Anal Biochem. 1972 Apr;46(2):489–501. doi: 10.1016/0003-2697(72)90323-5. [DOI] [PubMed] [Google Scholar]
  11. Jobin F., Lapointe F., Gagnon F. Platelet reactions and immune processes. VI. The effect of immunoglobulins and other plasma proteins on platelet surface interactions. Thromb Diath Haemorrh. 1971;25(1):86–97. [PubMed] [Google Scholar]
  12. Jorgensen L., Hovig T., Rowsell H. C., Mustard J. F. Adenosine diphosphate-induced platelet aggregation and vascular injury in swine and rabbits. Am J Pathol. 1970 Nov;61(2):161–176. [PMC free article] [PubMed] [Google Scholar]
  13. KELLERMEYER R. W., BRECKENRIDGE R. T. THE INFLAMMATORY PROCESS IN ACUTE GOUTY ARTHRITIS. I. ACTIVATION OF HAGEMAN FACTOR BY SODIUM URATE CRYSTALS. J Lab Clin Med. 1965 Feb;65:307–315. [PubMed] [Google Scholar]
  14. Kinlough-Rathbone R. L., Chahil AMAR, Packham M. A., Mustard J. F. Conditions influencing platelet lysis. Lab Invest. 1975 Mar;32(3):352–358. [PubMed] [Google Scholar]
  15. Kniker W. T., Cochrane C. G. The localization of circulating immune complexes in experimental serum sickness. The role of vasoactive amines and hydrodynamic forces. J Exp Med. 1968 Jan 1;127(1):119–136. doi: 10.1084/jem.127.1.119. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MCCARTY D. J., Jr, FAIRES J. S. A comparison of the duration of local anti-inflammatory effect of several adrenocorticosteroid esters--a bioassay technique. Curr Ther Res Clin Exp. 1963 May;5:284–290. [PubMed] [Google Scholar]
  17. MUSTARD J. F., MURPHY E. A., OGRYZLO M. A., SMYTHE H. A. BLOOD COAGULATION AND PLATELET ECONOMY IN SUBJECTS WITH PRIMARY GOUT. Can Med Assoc J. 1963 Dec 14;89:1207–1211. [PMC free article] [PubMed] [Google Scholar]
  18. Morel F. M., Baker R. F., Wayland H. Quantitation of human red blood cell fixation by glutaraldehyde. J Cell Biol. 1971 Jan;48(1):91–100. doi: 10.1083/jcb.48.1.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Morris C. D. Observations on the effect of glass beads on platelet aggregation and its relation to platelet stickiness. Thromb Diath Haemorrh. 1968 Dec 31;20(3):345–353. [PubMed] [Google Scholar]
  20. Movat H. Z., Weiser W. J., Glynn M. F., Mustard J. F. Platelet phagocytosis and aggregation. J Cell Biol. 1965 Dec;27(3):531–543. doi: 10.1083/jcb.27.3.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mueller-Eckhardt C., Lüscher E. F. Immune reactions of human blood platelets. II. The effect of latex particles coated with gammaglobulin in relation of complement activation. Thromb Diath Haemorrh. 1968 Nov 15;20(1):168–179. [PubMed] [Google Scholar]
  22. Mustard J. F., Glynn M. F., Nishizawa E. E., Packham M. A. Platelet-surface interactions: relationship to thrombosis and hemostasis. Fed Proc. 1967 Jan-Feb;26(1):106–114. [PubMed] [Google Scholar]
  23. Mustard J. F., Movat H. Z., Macmorine D. R., Sényi A. Release of permeability factors from the blood platelet. Proc Soc Exp Biol Med. 1965 Aug-Sep;119(4):988–991. doi: 10.3181/00379727-119-30356. [DOI] [PubMed] [Google Scholar]
  24. Nachman R. L., Weksler B., Ferris B. Increased vascular permeability produced by human platelet granule cationic extract. J Clin Invest. 1970 Feb;49(2):274–281. doi: 10.1172/JCI106237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Niewiarowski S., Senyi A. F., Gillies P. Plasmin-induced platelet aggregation and platelet release reaction. Effects on hemostasis. J Clin Invest. 1973 Jul;52(7):1647–1659. doi: 10.1172/JCI107345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Packham M. A., Nishizawa E. E., Mustard J. F. Response of platelets to tissue injury. Biochem Pharmacol. 1968 Mar;(Suppl):171–184. doi: 10.1016/0006-2952(68)90304-3. [DOI] [PubMed] [Google Scholar]
  27. Pfueller S. L., Lüscher E. F. Studies of the mechanisms of the human platelet release reaction induced by immunologic stimuli. II. The effects of zymosan. J Immunol. 1974 Mar;112(3):1211–1218. [PubMed] [Google Scholar]
  28. RATNOFF O. D., CRUM J. D. ACTIVATION OF HAGEMAN FACTOR BY SOLUTIONS OF ELLAGIC ACID. J Lab Clin Med. 1964 Mar;63:359–377. [PubMed] [Google Scholar]
  29. SPAET T. H., CINTRON J. STUDIES ON PLATELET FACTOR-3 AVAILABILITY. Br J Haematol. 1965 May;11:269–275. doi: 10.1111/j.1365-2141.1965.tb06587.x. [DOI] [PubMed] [Google Scholar]
  30. Skosey J. L., Chow D., Damgaard E., Sorensen L. B. Effect of cytochalasin B on response of human polymorphonuclear leukocytes to zymosan. J Cell Biol. 1973 Apr;57(1):237–240. doi: 10.1083/jcb.57.1.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Smith J. B., Ingerman C., Silver M. J. Persistence of thromboxane A2-like material and platelet release-inducing activity in plasma. J Clin Invest. 1976 Nov;58(5):1119–1122. doi: 10.1172/JCI108564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stanley P. E., Williams S. G. Use of the liquid scintillation spectrometer for determining adenosine triphosphate by the luciferase enzyme. Anal Biochem. 1969 Jun;29(3):381–392. doi: 10.1016/0003-2697(69)90323-6. [DOI] [PubMed] [Google Scholar]
  33. TRAUT E. F., KNIGHT A. A., SZANTO P. B., PASSERELLI E. W. Specific vascular changes in gout. J Am Med Assoc. 1954 Oct 9;156(6):591–593. doi: 10.1001/jama.1954.02950060017007. [DOI] [PubMed] [Google Scholar]
  34. Wallingford W. R., McCarty D. J. Differential membranolytic effects of microcrystalline sodium urate and calcium pyrophosphate dihydrate. J Exp Med. 1971 Jan 1;133(1):100–112. doi: 10.1084/jem.133.1.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Walsh P. N. Albumin density gradient separation and washing of platelets and the study of platelet coagulant activities. Br J Haematol. 1972 Feb;22(2):205–217. doi: 10.1111/j.1365-2141.1972.tb08801.x. [DOI] [PubMed] [Google Scholar]
  36. Weksler B. B., Coupal C. E. Platelet-dependent generation of chemotactic activity in serum. J Exp Med. 1973 Jun 1;137(6):1419–1430. doi: 10.1084/jem.137.6.1419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Weksler B. B., Nachman R. L. Rabbit platelet bactericidal protein. J Exp Med. 1971 Nov 1;134(5):1114–1130. doi: 10.1084/jem.134.5.1114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Zucker M. B., Grant R. A. Aggregation and release reaction induced in human blood platelets by zymosan. J Immunol. 1974 Mar;112(3):1219–1230. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES